CI — Cell Impact AB (publ) Balance Sheet
0.000.00%
- SEK115.72m
- SEK150.78m
- SEK37.33m
Annual balance sheet for Cell Impact AB (publ), fiscal year end - December 31st, SEK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 152 | 28.6 | 165 | 99.9 | 20.4 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 15.6 | 30.7 | 25.2 | 8.07 | 8.69 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 177 | 128 | 238 | 173 | 73 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 60.3 | 106 | 154 | 199 | 180 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 243 | 239 | 402 | 382 | 261 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 22.4 | 80 | 43.8 | 48.2 | 24.1 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 41 | 96.1 | 77.2 | 78.6 | 42.2 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | 202 | 143 | 324 | 303 | 219 |
| Total Liabilities & Shareholders' Equity | 243 | 239 | 402 | 382 | 261 |
| Total Common Shares Outstanding |